Please use this identifier to cite or link to this item:
Title: Pharmacokinetics of darunavir/ritonavir with etravirine both twice daily in human immunodeficiency virus-infected adolescents and young adults
Authors: Tim R. Cressey
Ram Yogev
Andrew Wiznia
Rohan Hazra
Patrick Jean-Philippe
Bobbie Graham
Amy Gonzalez
Paula Britto
Vincent J. Carey
Courtney V. Fletcher
Edward P. Acosta
Keywords: Medicine
Issue Date: 1-Sep-2017
Abstract: © The Author 2017. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. Data on the combination of darunavir/ritonavir and etravirine both given twice daily in adolescents/young adults are lacking. In this study, we assessed the pharmacokinetics of darunavir/ ritonavir 600/100 mg with etravirine 200 mg twice daily in 36 treatment-experienced human immunodeficiency virus-infected adolescents and young adults and found that exposures were comparable to those reported in adults.
ISSN: 20487207
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.

Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.